These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 23861693)

  • 1. New insights into the role of the immune microenvironment in breast carcinoma.
    de la Cruz-Merino L; Barco-Sánchez A; Henao Carrasco F; Nogales Fernández E; Vallejo Benítez A; Brugal Molina J; Martínez Peinado A; Grueso López A; Ruiz Borrego M; Codes Manuel de Villena M; Sánchez-Margalet V; Nieto-García A; Alba Conejo E; Casares Lagar N; Ibáñez Martínez J
    Clin Dev Immunol; 2013; 2013():785317. PubMed ID: 23861693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Immune Microenvironment in Breast Carcinoma: Predictive and Prognostic Role in the Neoadjuvant Setting.
    Badr NM; Berditchevski F; Shaaban AM
    Pathobiology; 2020; 87(2):61-74. PubMed ID: 31715606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of immune infiltrates in breast ductal carcinoma in situ.
    Chen XY; Yeong J; Thike AA; Bay BH; Tan PH
    Breast Cancer Res Treat; 2019 Aug; 177(1):17-27. PubMed ID: 31134489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The heterogeneous immune microenvironment in breast cancer is affected by hypoxia-related genes.
    Duechler M; Peczek L; Zuk K; Zalesna I; Jeziorski A; Czyz M
    Immunobiology; 2014 Feb; 219(2):158-65. PubMed ID: 24091277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication.
    Burugu S; Asleh-Aburaya K; Nielsen TO
    Breast Cancer; 2017 Jan; 24(1):3-15. PubMed ID: 27138387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma.
    Cunha LL; Morari EC; Guihen AC; Razolli D; Gerhard R; Nonogaki S; Soares FA; Vassallo J; Ward LS
    Clin Endocrinol (Oxf); 2012 Dec; 77(6):918-25. PubMed ID: 22738343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune microenvironment in colorectal cancer: a new hallmark to change old paradigms.
    de la Cruz-Merino L; Henao Carrasco F; Vicente Baz D; Nogales Fernández E; Reina Zoilo JJ; Codes Manuel de Villena M; Pulido EG
    Clin Dev Immunol; 2011; 2011():174149. PubMed ID: 22162710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and predictive value of tumor infiltrating lymphocytes in early breast cancer.
    Criscitiello C; Esposito A; Trapani D; Curigliano G
    Cancer Treat Rev; 2016 Nov; 50():205-207. PubMed ID: 27744144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive and prognostic significance of tumor-infiltrating lymphocytes in patients with breast cancer treated with neoadjuvant systemic therapy.
    Melichar B; Študentova H; Kalábová H; Vitásková D; Čermáková P; Hornychová H; Ryška A
    Anticancer Res; 2014 Mar; 34(3):1115-25. PubMed ID: 24596349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.
    Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between Molecular Subtypes and Stromal Immune Infiltration before and after Treatment in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
    Hamy AS; Bonsang-Kitzis H; De Croze D; Laas E; Darrigues L; Topciu L; Menet E; Vincent-Salomon A; Lerebours F; Pierga JY; Brain E; Feron JG; Benchimol G; Lam GT; Laé M; Reyal F
    Clin Cancer Res; 2019 Nov; 25(22):6731-6741. PubMed ID: 31515462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast.
    Campbell MJ; Baehner F; O'Meara T; Ojukwu E; Han B; Mukhtar R; Tandon V; Endicott M; Zhu Z; Wong J; Krings G; Au A; Gray JW; Esserman L
    Breast Cancer Res Treat; 2017 Jan; 161(1):17-28. PubMed ID: 27785654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer.
    Racioppi L; Nelson ER; Huang W; Mukherjee D; Lawrence SA; Lento W; Masci AM; Jiao Y; Park S; York B; Liu Y; Baek AE; Drewry DH; Zuercher WJ; Bertani FR; Businaro L; Geradts J; Hall A; Means AR; Chao N; Chang CY; McDonnell DP
    Nat Commun; 2019 Jun; 10(1):2450. PubMed ID: 31164648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer.
    Li F; Zhao Y; Wei L; Li S; Liu J
    Cancer Biol Ther; 2018 Aug; 19(8):695-705. PubMed ID: 29621426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor microenvironment of human breast cancer, and feline mammary carcinoma as a potential study model.
    Nascimento C; Ferreira F
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188587. PubMed ID: 34237352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage Biology and Mechanisms of Immune Suppression in Breast Cancer.
    Mehta AK; Kadel S; Townsend MG; Oliwa M; Guerriero JL
    Front Immunol; 2021; 12():643771. PubMed ID: 33968034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic significance of intratumoral CD8+ tumor-infiltrating lymphocytes in medullary carcinoma.
    Igari F; Sato E; Horimoto Y; Takahashi Y; Isomura T; Arakawa A; Kitano S; Saito M
    Hum Pathol; 2017 Dec; 70():129-138. PubMed ID: 29122657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Immune Landscape in Women Cancers.
    Timperi E; Vissio E; Marchiò C; Romano E
    Cancer Treat Res; 2020; 180():215-249. PubMed ID: 32215872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of transcriptomic determination of tumour-infiltrating lymphocytes in localised breast cancer.
    Truntzer C; Isambert N; Arnould L; Ladoire S; Ghiringhelli F
    Eur J Cancer; 2019 Oct; 120():97-106. PubMed ID: 31499385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid cells in circulation and tumor microenvironment of breast cancer patients.
    Toor SM; Syed Khaja AS; El Salhat H; Faour I; Kanbar J; Quadri AA; Albashir M; Elkord E
    Cancer Immunol Immunother; 2017 Jun; 66(6):753-764. PubMed ID: 28283696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.